Latest Articles

Publication Date
[Evaluation of the expectations of patients with endometriosis regarding the EndOccitanie care network].

The management of patients with endometriosis remains marked by a long, fragmented, and poorly coordinated care pathway, leading to significant diagnostic delay. In this context, the regional EndOccitanie network is …

Published: Aug. 14, 2026, midnight
Adolescent dysmenorrhea revealing Herlyn-Werner-Wunderlich syndrome with endometriosis: A radiologic case report.

Herlyn-Werner-Wunderlich syndrome, also referred to as obstructed hemivagina with ipsilateral renal agenesis (OHVIRA) is a rare congenital urogenital anomaly resulting from abnormal development of the Müllerian and Wolffian ducts, classically …

Published: Aug. 14, 2026, midnight
Endometriosis presenting as recurrent massive haemorrhagic ascites.

Haemorrhagic ascites (HA) is an uncommon clinical entity commonly caused by cirrhosis, malignancy and iatrogenic intervention. In the absence of these causes, it poses a diagnostic challenge. We present a …

Published: Aug. 13, 2026, midnight
Laparoscopic use of ethanol sclerotherapy in the treatment of endometriomas: a narrative review.

Endometriosis frequently involves the ovaries. Surgical management of endometriomas traditionally includes cystectomy, electrocoagulation, or ablative techniques. Ethanol sclerotherapy has emerged as a low-cost, time-efficient alternative. When performed laparoscopically, it allows …

Published: Aug. 13, 2026, midnight
Weighing Surgical Versus Medical Management in Endometriosis - Patient Care Online

Weighing Surgical Versus Medical Management in Endometriosis Patient Care Online

Published: Aug. 12, 2026, 2:45 p.m.
Weighing Surgical Versus Medical Management in Endometriosis - Contemporary OB/GYN

Weighing Surgical Versus Medical Management in Endometriosis Contemporary OB/GYN

Published: Aug. 12, 2026, 12:15 p.m.
Cannabis-Based Medicinal Products for Endometriosis: A 2-Year Prospective Analysis From the UK Medical Cannabis Registry.

Endometriosis affects up to 10% of biological females of reproductive age. Current treatment options are limited and often unsuitable for prolonged use. Cannabis-based medicinal products (CBMPs) have emerged as an …

Published: Aug. 12, 2026, midnight
Hormonal therapies for endometriosis-associated pain: inflammatory limitations and pharmacological challenges.

Endometriosis is a chronic inflammatory and estrogen-dependent disease in which pain remains the leading cause of impaired quality of life. Hormonal therapies constitute the cornerstone of medical management and include …

Published: Aug. 11, 2026, midnight
Clinical Impact of HPV Self-Sampling and Molecular Biomarkers on Cervical Cancer Screening and Triage: "The Times They Are A-Changin'"-A Comprehensive Review and Future Perspectives.

Human papillomavirus (HPV) infection is a necessary but insufficient cause of cervical cancer (CC) and reflects a long-standing host-virus equilibrium shaped by immune control, viral persistence, and latency. The transition …

Published: Aug. 11, 2026, midnight
Beyond the Mass Effect: Decoupling Endometrioma Size and Bilaterality from Ovarian Reserve Depletion.

Ovarian endometriomas are commonly assessed according to cyst size and laterality, anatomical features that have long been regarded as indicators of disease severity and potential ovarian compromise. Consequently, these characteristics …

Published: Aug. 9, 2026, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!